Research ArticleClinical Investigations
Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
Farrokh Dehdashti, Richard Laforest, Feng Gao, Rebecca L. Aft, Carmen S. Dence, Dong Zhou, Kooresh I. Shoghi, Barry A. Siegel, John A. Katzenellenbogen and Michael J. Welch
Journal of Nuclear Medicine March 2012, 53 (3) 363-370; DOI: https://doi.org/10.2967/jnumed.111.098319
Farrokh Dehdashti
Richard Laforest
Feng Gao
Rebecca L. Aft
Carmen S. Dence
Dong Zhou
Kooresh I. Shoghi
Barry A. Siegel
John A. Katzenellenbogen

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 3
March 1, 2012
Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
Farrokh Dehdashti, Richard Laforest, Feng Gao, Rebecca L. Aft, Carmen S. Dence, Dong Zhou, Kooresh I. Shoghi, Barry A. Siegel, John A. Katzenellenbogen, Michael J. Welch
Journal of Nuclear Medicine Mar 2012, 53 (3) 363-370; DOI: 10.2967/jnumed.111.098319
Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
Farrokh Dehdashti, Richard Laforest, Feng Gao, Rebecca L. Aft, Carmen S. Dence, Dong Zhou, Kooresh I. Shoghi, Barry A. Siegel, John A. Katzenellenbogen, Michael J. Welch
Journal of Nuclear Medicine Mar 2012, 53 (3) 363-370; DOI: 10.2967/jnumed.111.098319
Jump to section
Related Articles
Cited By...
- Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation
- Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
- Measuring Estrogen Receptor Functionality Using Progesterone Receptor PET Imaging: Rising to the (Estradiol) Challenge!
- Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer
- Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
- Quo Vadis: PET and Single-Photon Molecular Breast Imaging
- Longitudinal Noninvasive Imaging of Progesterone Receptor as a Predictive Biomarker of Tumor Responsiveness to Estrogen Deprivation Therapy
- Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
- Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer